Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead ...
A negative relationship between viral replication and liver inflammation in HBeAg-positive patients with high HBV DNA, which changed to a positive relationship for those HBeAg-positive patients with ...
Zika virus (ZIKV) is a mosquito-borne orthoflavivirus that can cause birth defects, including microcephaly, a condition in which head and brain size are significantly reduced at birth. The collective ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
The discovery of a giant virus called Ushikuvirus offers inklings into the origin and evolution of our complex cells and new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback